Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
4.450
+0.020 (0.45%)
At close: Jan 21, 2025, 4:00 PM
4.500
+0.050 (1.12%)
After-hours: Jan 21, 2025, 6:38 PM EST
Terns Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for TERN stock have an average target of 18.3, with a low estimate of 7.50 and a high estimate of 26. The average target predicts an increase of 311.24% from the current stock price of 4.45.
Analyst Consensus: Buy
* Price targets were last updated on Dec 4, 2024.
Analyst Ratings
The average analyst rating for TERN stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 5 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +349.44% | Dec 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +349.44% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7.5 | Hold | Reiterates | $7.5 | +68.54% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5.5 → $7.5 | Hold | Maintains | $5.5 → $7.5 | +68.54% | Nov 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +282.02% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.22
from -1.27
EPS Next Year
-1.36
from -1.22
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.23 | -1.18 | -1.41 | |||
| Avg | -1.22 | -1.36 | -1.52 | |||
| Low | -1.22 | -1.45 | -1.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.